Medinet Co (TSE:2370) Beneish M-Score: -2.15 (As of Jul. 13, 2026)


TSE:2370 Medinet Co Ltd TSE:2370
41 GF Score
Price 円25.00
GF Value 円41.74
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Medinet Co Beneish M-Score?

Medinet Co TSE:2370 41 Beneish M-Score is -2.15 as of Jul. 13, 2026. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 825 Biotechnology companies, Medinet Co ranks worse than 57.33% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.15 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medinet Co's Beneish M-Score or its related term are showing as below:

TSE:2370' s Beneish M-Score Range Over the Past 10 Years
Min: -3.54   Med: -2.49   Max: -1.85
Current: -2.15

During the past 13 years, the highest Beneish M-Score of Medinet Co was -1.85. The lowest was -3.54. And the median was -2.49.


Medinet Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medinet Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinet Co Beneish M-Score Chart

Medinet Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.31 -2.23 -2.48 -2.50 -2.15

Medinet Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.15 0.00 0.00

TSE:2370 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Medinet Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medinet Co's Beneish M-Score falls into.


TSE:2370
41GF Score
Medinet Co Ltd TSE:2370
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinet Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medinet Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0648+0.528 * 1.0829+0.404 * 1.4492+0.892 * 1.0544+0.115 * 0.9626
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.012041-0.327 * 1.1615
=-2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep25) TTM:Last Year (Sep24) TTM:
Total Receivables was 円255.8 Mil.
Revenue was 円810.3 Mil.
Gross Profit was 円109.7 Mil.
Total Current Assets was 円3,611.6 Mil.
Total Assets was 円4,254.1 Mil.
Property, Plant and Equipment(Net PPE) was 円356.6 Mil.
Depreciation, Depletion and Amortization(DDA) was 円101.6 Mil.
Selling, General, & Admin. Expense(SGA) was 円0.0 Mil.
Total Current Liabilities was 円233.1 Mil.
Long-Term Debt & Capital Lease Obligation was 円0.0 Mil.
Net Income was 円-1,362.1 Mil.
Gross Profit was 円0.0 Mil.
Cash Flow from Operations was 円-1,413.4 Mil.
Total Receivables was 円227.8 Mil.
Revenue was 円768.5 Mil.
Gross Profit was 円112.7 Mil.
Total Current Assets was 円5,013.1 Mil.
Total Assets was 円5,700.0 Mil.
Property, Plant and Equipment(Net PPE) was 円422.7 Mil.
Depreciation, Depletion and Amortization(DDA) was 円114.7 Mil.
Selling, General, & Admin. Expense(SGA) was 円0.0 Mil.
Total Current Liabilities was 円268.9 Mil.
Long-Term Debt & Capital Lease Obligation was 円0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(255.76 / 810.291) / (227.801 / 768.501)
=0.31564 / 0.296423
=1.0648

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(112.692 / 768.501) / (109.721 / 810.291)
=0.146639 / 0.135409
=1.0829

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3611.617 + 356.621) / 4254.07) / (1 - (5013.076 + 422.683) / 5700.031)
=0.06719 / 0.046363
=1.4492

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=810.291 / 768.501
=1.0544

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(114.651 / (114.651 + 422.683)) / (101.563 / (101.563 + 356.621))
=0.21337 / 0.221664
=0.9626

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 810.291) / (0 / 768.501)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 233.11) / 4254.07) / ((0 + 268.922) / 5700.031)
=0.054797 / 0.047179
=1.1615

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1362.138 - 0 - -1413.36) / 4254.07
=0.012041

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medinet Co has a M-score of -2.15 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.15 mean?
Medinet Co (TSE:2370) has a Beneish M-Score of -2.15 as of Jul. 13, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medinet Co and its competitors. According to the industry distribution chart, Medinet Co ranks #473 out of 825 companies in the Biotechnology industry, placing it in the top 57.3%.
Is Medinet Co's Beneish M-Score too high?
Medinet Co's current Beneish M-Score is -2.15. Based on the distribution chart, Medinet Co ranks #473 out of 825 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #473 out of 825 companies for Beneish M-Score. This places Medinet Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medinet Co and its competitors. Medinet Co's current Beneish M-Score is -2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current Beneish M-Score is -2.15. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Beneish M-Score is -2.15 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinet Co (TSE:2370) Overvalued in 2026?

Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued. The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74. GuruFocus considers Medinet Co to be Possible Value Trap.

Key valuation signals for TSE:2370:

  • Beneish M-Score: -2.15
  • GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medinet Co Business Description

Address 1-1 Heiwajima 6-chome, 9th Floor, TRC Center Building, Ota-ku, Yokohama, JPN, 143-0006
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score

Get the complete analysis for TSE:2370

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円25.00
Price
円41.74
GF Value